This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O'Neal, C. M.
Right arrow Articles by Conner, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Neal, C. M.
Right arrow Articles by Conner, M. E.

 Previous Article  |  Next Article 

J Virol, April 1998, p. 3390-3393, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Rotavirus 2/6 Viruslike Particles Administered Intranasally with Cholera Toxin, Escherichia coli Heat-Labile Toxin (LT), and LT-R192G Induce Protection from Rotavirus Challenge

Christine M. O'Neal,1 John D. Clements,2 Mary K. Estes,1 and Margaret E. Conner1,*

Division of Molecular Virology, Baylor College of Medicine, Houston, Texas 77030,1 and Department of Microbiology and Immunology, Tulane University Medical Center, New Orleans, Louisiana 701122

Received 1 October 1997/Accepted 16 December 1997

We have shown that rotavirus 2/6 viruslike particles composed of proteins VP2 and VP6 (2/6-VLPs) administered to mice intranasally with cholera toxin (CT) induced protection from rotavirus challenge, as measured by virus shedding. Since it is unclear if CT will be approved for human use, we evaluated the adjuvanticity of Escherichia coli heat-labile toxin (LT) and LT-R192G. Mice were inoculated intranasally with 10 µg of 2/6-VLPs combined with CT, LT, or LT-R192G. All three adjuvants induced equivalent geometric mean titers of rotavirus-specific serum antibody and intestinal immunoglobulin G (IgG). Mice inoculated with 2/6-VLPs with LT produced significantly higher titers of intestinal IgA than mice given CT as the adjuvant. All mice inoculated with 2/6-VLPs mixed with LT and LT-R192G were totally protected (100%) from rotavirus challenge, while mice inoculated with 2/6-VLPs mixed with CT showed a mean 91% protection from challenge. The availability of a safe, effective mucosal adjuvant such as LT-R192G will increase the practicality of administering recombinant vaccines mucosally.


* Corresponding author. Mailing address: Rm. 936E, Division of Molecular Virology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Phone: (713) 798-3590. Fax: (713) 798-3586. E-mail: mconner{at}bcm.tmc.edu.




This article has been cited by other articles:

  • Blutt, S. E., Warfield, K. L., Estes, M. K., Conner, M. E. (2008). Differential Requirements for T Cells in Viruslike Particle- and Rotavirus-Induced Protective Immunity. J. Virol. 82: 3135-3138 [Abstract] [Full Text]  
  • Di Martino, C., Basset, C., Ogier, A., Charpilienne, A., Poncet, D., Kohli, E. (2007). Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes. J. Leukoc. Biol. 82: 821-828 [Abstract] [Full Text]  
  • Quan, F.-S., Huang, C., Compans, R. W., Kang, S.-M. (2007). Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus. J. Virol. 81: 3514-3524 [Abstract] [Full Text]  
  • VanCott, J. L., Prada, A. E., McNeal, M. M., Stone, S. C., Basu, M., Huffer, B. Jr., Smiley, K. L., Shao, M., Bean, J. A., Clements, J. D., Choi, A. H.-C., Ward, R. L. (2006). Mice Develop Effective but Delayed Protective Immune Responses When Immunized as Neonates either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates.. J. Virol. 80: 4949-4961 [Abstract] [Full Text]  
  • Agnello, D., Herve, C. A., Lavaux, A., Darniot, M., Guillon, P., Charpilienne, A., Pothier, P. (2006). Intrarectal Immunization with Rotavirus 2/6 Virus-Like Particles Induces an Antirotavirus Immune Response Localized in the Intestinal Mucosa and Protects against Rotavirus Infection in Mice.. J. Virol. 80: 3823-3832 [Abstract] [Full Text]  
  • Parez, N., Fourgeux, C., Mohamed, A., Dubuquoy, C., Pillot, M., Dehee, A., Charpilienne, A., Poncet, D., Schwartz-Cornil, I., Garbarg-Chenon, A. (2006). Rectal Immunization with Rotavirus Virus-Like Particles Induces Systemic and Mucosal Humoral Immune Responses and Protects Mice against Rotavirus Infection. J. Virol. 80: 1752-1761 [Abstract] [Full Text]  
  • Glynn, A., Roy, C. J., Powell, B. S., Adamovicz, J. J., Freytag, L. C., Clements, J. D. (2005). Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens. Infect. Immun. 73: 5256-5261 [Abstract] [Full Text]  
  • Azevedo, M. S. P., Yuan, L., Iosef, C., Chang, K.-O., Kim, Y., Van Nguyen, T., Saif, L. J. (2004). Magnitude of Serum and Intestinal Antibody Responses Induced by Sequential Replicating and Nonreplicating Rotavirus Vaccines in Gnotobiotic Pigs and Correlation with Protection. CVI 11: 12-20 [Abstract] [Full Text]  
  • Fromantin, C., Jamot, B., Cohen, J., Piroth, L., Pothier, P., Kohli, E. (2001). Rotavirus 2/6 Virus-Like Particles Administered Intranasally in Mice, with or without the Mucosal Adjuvants Cholera Toxin and Escherichia coli Heat-Labile Toxin, Induce a Th1/Th2-Like Immune Response. J. Virol. 75: 11010-11016 [Abstract] [Full Text]  
  • Guerrero, R. A., Ball, J. M., Krater, S. S., Pacheco, S. E., Clements, J. D., Estes, M. K. (2001). Recombinant Norwalk Virus-Like Particles Administered Intranasally to Mice Induce Systemic and Mucosal (Fecal and Vaginal) Immune Responses. J. Virol. 75: 9713-9722 [Abstract] [Full Text]  
  • Yuan, L., Iosef, C., Azevedo, M. S. P., Kim, Y., Qian, Y., Geyer, A., Nguyen, T. V., Chang, K.-O., Saif, L. J. (2001). Protective Immunity and Antibody-Secreting Cell Responses Elicited by Combined Oral Attenuated Wa Human Rotavirus and Intranasal Wa 2/6-VLPs with Mutant Escherichia coli Heat-Labile Toxin in Gnotobiotic Pigs. J. Virol. 75: 9229-9238 [Abstract] [Full Text]  
  • Gerber, S., Lane, C., Brown, D. M., Lord, E., DiLorenzo, M., Clements, J. D., Rybicki, E., Williamson, A.-L., Rose, R. C. (2001). Human Papillomavirus Virus-Like Particles Are Efficient Oral Immunogens when Coadministered with Escherichia coli Heat-Labile Enterotoxin Mutant R192G or CpG DNA. J. Virol. 75: 4752-4760 [Abstract] [Full Text]  
  • Belyakov, I. M., Ahlers, J. D., Clements, J. D., Strober, W., Berzofsky, J. A. (2000). Interplay of Cytokines and Adjuvants in the Regulation of Mucosal and Systemic HIV-Specific CTL. J. Immunol. 165: 6454-6462 [Abstract] [Full Text]  
  • Yuan, L., Geyer, A., Hodgins, D. C., Fan, Z., Qian, Y., Chang, K.-O., Crawford, S. E., Parreño, V., Ward, L. A., Estes, M. K., Conner, M. E., Saif, L. J. (2000). Intranasal Administration of 2/6-Rotavirus-Like Particles with Mutant Escherichia coli Heat-Labile Toxin (LT-R192G) Induces Antibody-Secreting Cell Responses but Not Protective Immunity in Gnotobiotic Pigs. J. Virol. 74: 8843-8853 [Abstract] [Full Text]  
  • Ciarlet, M., Estes, M. K., Conner, M. E. (2000). Simian rhesus rotavirus is a unique heterologous (non-lapine) rotavirus strain capable of productive replication and horizontal transmission in rabbits. J. Gen. Virol. 81: 1237-1249 [Abstract] [Full Text]  
  • McNeal, M. M., Rae, M. N., Bean, J. A., Ward, R. L. (1999). Antibody-Dependent and -Independent Protection following Intranasal Immunization of Mice with Rotavirus Particles. J. Virol. 73: 7565-7573 [Abstract] [Full Text]  
  • Choi, A. H.-C., Basu, M., McNeal, M. M., Clements, J. D., Ward, R. L. (1999). Antibody-Independent Protection against Rotavirus Infection of Mice Stimulated by Intranasal Immunization with Chimeric VP4 or VP6 Protein. J. Virol. 73: 7574-7581 [Abstract] [Full Text]  
  • Ryan, E. T., Crean, T. I., John, M., Butterton, J. R., Clements, J. D., Calderwood, S. B. (1999). In Vivo Expression and Immunoadjuvancy of a Mutant of Heat-Labile Enterotoxin of Escherichia coli in Vaccine and Vector Strains of Vibrio cholerae. Infect. Immun. 67: 1694-1701 [Abstract] [Full Text]  
  • Cardenas-Freytag, L., Cheng, E., Mayeux, P., Domer, J. E., Clements, J. D. (1999). Effectiveness of a Vaccine Composed of Heat-Killed Candida albicans and a Novel Mucosal Adjuvant, LT(R192G), against Systemic Candidiasis. Infect. Immun. 67: 826-833 [Abstract] [Full Text]  
  • Ciarlet, M., Crawford, S. E., Barone, C., Bertolotti-Ciarlet, A., Ramig, R. F., Estes, M. K., Conner, M. E. (1998). Subunit Rotavirus Vaccine Administered Parenterally to Rabbits Induces Active Protective Immunity. J. Virol. 72: 9233-9246 [Abstract] [Full Text]